Reversing memory deficits and impairments in spatial learning is a major goal in the field of dementia research. A lack of knowledge about cellular pathways critical to the development of dementia, however, has stood in the way of significant clinical advance. But now, researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) are breaking through that barrier. They show, for the first time in an animal model, that tau pathology – the second-most important lesion in the brain in patients with Alzheimer’s disease – can be reversed by a drug.
“We show that we can intervene after disease is established and pharmacologically rescue mice that have tau-induced memory deficits,” explained senior investigator Domenico Praticò, MD, Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple at LKSOM. The study, published online in the journal Molecular Neurobiology, raises new hope for human patients affected by dementia.
The researchers landed on their breakthrough after discovering that inflammatory molecules known as leukotrienes are deregulated in Alzheimer’s disease and related dementias. In experiments in animals, they found that the leukotriene pathway plays an especially important role in the later stages of disease.
“At the onset of dementia, leukotrienes attempt to protect nerve cells, but over the long term, they cause damage,” Dr. Praticò said. “Having discovered this, we wanted to know whether blocking leukotrienes could reverse the damage, whether we could do something to fix memory and learning impairments in mice having already abundant tau pathology.”
To recapitulate the clinical situation of dementia in humans, in which patients are already symptomatic by the time they are diagnosed, Dr. Praticò and colleagues used specially engineered tau transgenic mice, which develop tau pathology – characterized by neurofibrillary tangles, disrupted synapses (the junctions between neurons that allow them to communicate with one another), and declines in memory and learning ability – as they age. When the animals were 12 months old, the equivalent of age 60 in humans, they were treated with zileuton, a drug that inhibits leukotriene formation by blocking the 5-lipoxygenase enzyme.
After 16 weeks of treatment, animals were administered maze tests to assess their working memory and their spatial learning memory. Compared with untreated animals, tau mice that had received zileuton performed significantly better on the tests. Their superior performance suggested a successful reversal of memory deficiency.
To determine why this happened, the researchers first analyzed leukotriene levels. They found that treated tau mice experienced a 90-percent reduction in leukotrienes compared with untreated mice. In addition, levels of phosphorylated and insoluble tau, the form of the protein that is known to directly damage synapses, were 50 percent lower in treated animals. Microscopic examination revealed vast differences in synaptic integrity between the groups of mice. Whereas untreated animals had severe synaptic deterioration, the synapses of treated tau animals were indistinguishable from those of ordinary mice without the disease.
“Inflammation was completely gone from tau mice treated with the drug,” Dr. Praticò said. “The therapy shut down inflammatory processes in the brain, allowing the tau damage to be reversed.”
The study is especially exciting because zileuton is already approved by the Food and Drug Administration for the treatment of asthma. “Leukotrienes are in the lungs and the brain, but we now know that in addition to their functional role in asthma, they also have a functional role in dementia,” Dr. Praticò explained.
“This is an old drug for a new disease,” he added. “The research could soon be translated to the clinic, to human patients with Alzheimer’s disease.”
Receive an email update when we add a new DEMENTIA article.
The Latest on: Dementia
via Google News
The Latest on: Dementia
- Local doctor's research paints positive future for dementia prevention on February 19, 2019 at 2:58 pm
With a lack of success in treating dementia, a local doctor said the future for the prevention of dementia is looking clearer thanks to new research findings. Dr. Valerie Wilson, a doctor at the Mount... […]
- For those with dementia, music brings comfort, connection and joy on February 19, 2019 at 2:37 pm
In an inconspicuous room on the top floor of Ottawa’s Southminster United, a small group of people suffering from dementia and their carers are gathered. Chris White, one of the group’s leaders, amiab... […]
- Study finds dementia takes away the ability to daydream on February 19, 2019 at 12:29 pm
A heartbreaking study out of the University of Sydney has found that people suffering from a type of early-onset dementia lose their ability to daydream and engage in inner monologues. Without the abi... […]
- Lethal Prions and Alzheimer’s; Cannabis and Dementia; Baby Brains and Autism on February 19, 2019 at 8:29 am
What separates lethal prions from Alzheimer's-related amyloid plaques? Scientific American takes a look. A landmark cannabis-based medicine trial will target dementia residents with symptoms of agitat... […]
- Consumers at High Risk for Dementia Put More Wealth in CDs: Researchers on February 19, 2019 at 7:31 am
Your article was successfully shared with the contacts you provided. People who know they are growing more forgetful may have a tendency to simplify their investments — or their children may make them ... […]
- FDA warns consumers against ‘young blood’ plasma infusions for dementia, PTSD and other conditions on February 19, 2019 at 7:14 am
Federal health regulators on Tuesday warned consumers against controversial “young blood” treatments -- plasma infusions from young donors marketed for conditions such as Parkinson’s, Alzheimer’s, mul... […]
- MCI won't stop this guy: Former ND deputy state's attorney to speak at annual dementia conference on February 19, 2019 at 6:37 am
EAST GRAND FORKS, Minn. — For some people, it can start slowly. They misplace valuable objects, start to forget important information like appointments, conversations or recent events, or their abilit... […]
- Isle of Wight dementia sufferer left with just pyjamas on February 19, 2019 at 6:33 am
A dementia patient was transferred to the wrong care home in just his pyjamas and with no medication, it has been claimed. Michael McLaughlin, 73, had spent two weeks in hospital and was set to move t... […]
- Woman With Dementia Walked 400 Miles To See Son Nearby, Returns Home on February 19, 2019 at 3:44 am
A Thai woman with dementia, who accidentally walked 400 miles to China after leaving home to see her son nearby in June last year, returned home Friday. Kaeomanee Arjaw, 59, lived in the Thai province ... […]
via Bing News